Monthly Archives: December 2012

Major Step Forward for Ethical Stem Cell Research

Eugene C. Tarne  

A major New England biotech company recently announced that it would begin the process that it hopes will result in the first clinical trial using induced pluripotent stem cells (iPSCs).     This is hardly surprising, as the discovery, by Shinya Yamanaka, of the process to produce embryonic-like, fully pluripotent stem cells from ordinary somatic (body) cells has […]

Sick and Disabled Infants Starved and Dehydrated: Britain’s Modern Baby Doe

Charlotte Lozier Institute  

By Jacqueline H. Abernathy, Ph.D.

A news article entitled “Now sick babies go on death pathway: Doctor’s haunting testimony reveals how children are put on end-of-life plan” from the UK’s Daily Mail is commanding considerable attention to end-of-life care in Great Britain. The article cites commentary from the British Medical Journal (BMJ) by an anonymous physician, who admits that he/she oversees the intentional starvation and dehydration of infants with disabilities, a practice previously thought to apply only to the elderly and terminally-ill under the controversial Liverpool Care Pathway (LCP) protocol for palliative care in the U.K.

Life-Issue Think Tank Announces Associate Scholars

Charlotte Lozier Institute  

FOR IMMEDIATE RELEASE: December 4, 2012 Contact: Mallory Quigley, 202-223-8073     Life-Issue Think Tank Announces Associate Scholars    Charlotte Lozier Institute Names New Contributors to Counter Abortion Industry-Influenced Policy Research     Washington, D.C. – The Charlotte Lozier Institute, the education and research arm of Susan B. Anthony List, announced today a list of associate scholars from across […]

The Ethical Stems of Good Science

Eugene C. Tarne  

This paper examines the funding pattern of the California Institute for Regenerative Medicine, an institution which characterizes itself as the “largest source of funding for stem cell research outside the NIH.” Tarne demonstrates that funding has moved from grants directed primarily towards embryonic stem cell research toward primarily ethical stem cells research – which has been the only stem cell research to date to result in positive treatments for illnesses.